Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2002346053 (hide)

Owner Merck & Co., Inc.

Inventors Bilodeau, Mark T.; Hartman, George D.

Agent Spruson & Ferguson

Pub. Number AU-B-2002346053

PCT Number PCT/US02/21110

PCT Pub. Number WO2003/000687

Priority 60/300,245 22.06.01 US

Filing date 18 June 2002

Wipo publication date 8 January 2003

Acceptance publication date 13 March 2008

International Classifications

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/09 (2006.01)

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/4439 (2006.01)

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/4535 (2006.01)

A61K 31/454 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/737 (2006.01) - Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

Event Publications

6 March 2003 Complete Application Filed

  Priority application(s): 60/300,245 22.06.01 US

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002346053

13 March 2008 Application Accepted

  Published as AU-B-2002346053

10 July 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002346054-Shaped interlayer for heads-up display windshields and process for preparing same

2002346052-ZONISAMIDE USE IN HEADACHE